Novel HER3/MUC4 oncogenic signaling aggravates the tumorigenic phenotypes of pancreatic cancer cells
about
Functional Consequences of Differential O-glycosylation of MUC1, MUC4, and MUC16 (Downstream Effects on Signaling)Association between BRAF V600E Mutation and Ultrasound Features in Papillary Thyroid Carcinoma Patients with and without Hashimoto's ThyroiditisThe canonical Wnt pathway regulates the metastasis-promoting mucin MUC4 in pancreatic ductal adenocarcinoma.PR55α Subunit of Protein Phosphatase 2A Supports the Tumorigenic and Metastatic Potential of Pancreatic Cancer Cells by Sustaining Hyperactive Oncogenic Signaling.MUC4 is negatively regulated through the Wnt/β-catenin pathway via the Notch effector Hath1 in colorectal cancer.Loss of N-acetylgalactosaminyltransferase 3 in poorly differentiated pancreatic cancer: augmented aggressiveness and aberrant ErbB family glycosylation.NIDO, AMOP and vWD domains of MUC4 play synergic role in MUC4 mediated signalingCell membrane-anchored MUC4 promotes tumorigenicity in epithelial carcinomas.MUC4 mucin- a therapeutic target for pancreatic ductal adenocarcinoma.MUC5AC interactions with integrin β4 enhances the migration of lung cancer cells through FAK signaling.Mucins in pancreatic cancer: biological role, implications in carcinogenesis and applications in diagnosis and therapy.Bile acids-mediated overexpression of MUC4 via FAK-dependent c-Jun activation in pancreatic cancer.Prognostic significance of HER3 in patients with malignant solid tumors.Posttranscriptional upregulation of HER3 by HER2 mRNA induces trastuzumab resistance in breast cancer
P2860
Q26739942-E1A11A94-1ACB-4BF0-BA5C-32E7A3A87691Q33884794-A02D771D-A77D-499F-889F-0C40E0B0EBBAQ36540519-59A1EEF9-A802-41AC-BDDD-05F364327C74Q36917818-264296FF-152C-4021-A65B-DB3D64F4702CQ37164549-6BE15686-6E49-45B7-9D6F-EF27EE137D1BQ37174016-0CAD9AE0-0ED3-45D8-9271-329FAEA09395Q37705843-C704F931-61EC-48C7-ACD1-E9586E67EFC9Q37706759-1296E1EF-C2A6-439A-9EF5-76542CBB9436Q38688917-AF53CD6C-7C3B-4C65-99F0-25CA46D1017BQ38804960-C106E55C-0479-445A-ADD5-F33AF2794583Q39410445-A4186A18-C292-4E6E-AFFF-C2D97377E679Q41859754-A8C93B6E-36CF-4613-A117-F744BC0E3427Q42148898-BB8950BA-AB4B-4B68-9A7C-56798A842F3EQ58803127-F2034613-61AC-40C1-8701-A3C3D36915E1
P2860
Novel HER3/MUC4 oncogenic signaling aggravates the tumorigenic phenotypes of pancreatic cancer cells
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Novel HER3/MUC4 oncogenic sign ...... pes of pancreatic cancer cells
@ast
Novel HER3/MUC4 oncogenic sign ...... pes of pancreatic cancer cells
@en
type
label
Novel HER3/MUC4 oncogenic sign ...... pes of pancreatic cancer cells
@ast
Novel HER3/MUC4 oncogenic sign ...... pes of pancreatic cancer cells
@en
prefLabel
Novel HER3/MUC4 oncogenic sign ...... pes of pancreatic cancer cells
@ast
Novel HER3/MUC4 oncogenic sign ...... pes of pancreatic cancer cells
@en
P2093
P2860
P356
P1433
P1476
Novel HER3/MUC4 oncogenic sign ...... pes of pancreatic cancer cells
@en
P2093
Apar K Ganti
Chittibabu Guda
Dhanya Haridas
Imayavaramban Lakshmanan
Maneesh Jain
Moorthy P Ponnusamy
Parthasarathy Seshacharyulu
Satyanarayana Rachagani
Suhasini Joshi
Suprit Gupta
P2860
P304
21085-21099
P356
10.18632/ONCOTARGET.3912
P407
P577
2015-05-16T00:00:00Z